NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors

Published:2024-10 Issue: Volume:208 Page:107375
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Sharma Nutan,Singh Lakhwinder,Sharma Aditya,Kumar Ajay,Mahajan Dinesh

Funder

Science and Engineering Research Board

Department of Science and Technology, Ministry of Science and Technology, India

Department of Biotechnology

Biotechnology Industry Research Assistance Council

Publisher

Elsevier BV

Reference160 articles.

1. Natural history of NAFLD: remarkably benign in the absence of cirrhosis;Day;Gastroenterology,2005

2. Toward more accurate nomenclature for fatty liver diseases;Eslam;Gastroenterology,2019

3. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement;Eslam;J. Hepatol.,2020

4. A multisociety Delphi consensus statement on new fatty liver disease nomenclature;Rinella;Ann. Hepatol.,2024

5. Nonalcoholic fatty liver disease gets renamed as metabolic dysfunction–associated steatotic liver disease: progress but with challenges;Allen;Gastroenterology,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP